Althunian, T. A., de Boer, A., Groenwold, R. H. H., Rengerink, K. O., Souverein, P. C., & Klungel, O. H. (2020). Rivaroxaban was found to be noninferior to warfarin in routine clinical care: A retrospective noninferiority cohort replication study. Pharmacoepidemiol Drug Saf.
Styl cytowania ChicagoAlthunian, Turki A., Anthonius de Boer, Rolf H. H. Groenwold, Katrien O. Rengerink, Patrick C. Souverein, i Olaf H. Klungel. "Rivaroxaban Was Found to Be Noninferior to Warfarin in Routine Clinical Care: A Retrospective Noninferiority Cohort Replication Study." Pharmacoepidemiol Drug Saf 2020.
Styl cytowania MLAAlthunian, Turki A., et al. "Rivaroxaban Was Found to Be Noninferior to Warfarin in Routine Clinical Care: A Retrospective Noninferiority Cohort Replication Study." Pharmacoepidemiol Drug Saf 2020.